GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (XTER:DC4) » Definitions » Institutional Ownership

DexCom (XTER:DC4) Institutional Ownership : 75.32% (As of May. 25, 2024)


View and export this data going back to 1990. Start your Free Trial

What is DexCom Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DexCom's institutional ownership is 75.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DexCom's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DexCom's Float Percentage Of Total Shares Outstanding is 88.52%.


DexCom Institutional Ownership Historical Data

The historical data trend for DexCom's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Institutional Ownership Chart

DexCom Historical Data

The historical data trend for DexCom can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 79.99 78.11 78.42 74.00 74.66 79.47 79.58 79.29 75.66 75.32

DexCom Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


DexCom (XTER:DC4) Business Description

Traded in Other Exchanges
Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom (XTER:DC4) Headlines

No Headlines